The Best Asset Doesn’t Have a Passport

The heart of the next MedTech wave beats in Europe

Investing in the age of bioconvergence

MIG’s new Investment: TIBEAY biosciences

Information on business performance for the year 2025

Quantum-Start-Up IQM Goes Public

Fewer bets, more conviction

GlassPoint raises $20 M for solar stream

AC Immune gives Parkinson’s patients hope

Financing of 16 million euros for the new MIG portfolio company NcodiN